In The News,
ADVI Director, Lindsay Bealor Greenleaf, talked with CNBC about the Administration’s proposed rule on rebates and what it could mean for drug prices and PBMs
[el-text]
Written by Bertha Coombs and Christine Wang
***excerpt***
“The market consolidation that we’ve seen with pharmacy benefits managers makes it harder for manufacturers to push back against this demand for rebates” explained Lindsay Bealor Greenleaf, a director at ADVI Health, a health care policy consultancy.
***end excerpt***
***
[/el-text]